Asia Pacific Hereditary Testing Market Size & Outlook

The hereditary testing market in Asia Pacific is expected to reach a projected revenue of US$ 3,021.9 million by 2030. A compound annual growth rate of 9.2% is expected of Asia Pacific hereditary testing market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,629.6
Forecast, 2030 (US$M)
$3,021.9
CAGR, 2024 - 2030
9.2%
Report Coverage
Asia Pacific

Asia Pacific hereditary testing market, 2018-2030 (US$M)

Asia

Asia Pacific hereditary testing market highlights

  • The Asia Pacific hereditary testing market generated a revenue of USD 1,629.6 million in 2023.
  • The market is expected to grow at a CAGR of 9.2% from 2024 to 2030.
  • In terms of segment, hereditary non-cancer testing was the largest revenue generating disease type in 2023.
  • Hereditary Cancer Testing is the most lucrative disease type segment registering the fastest growth during the forecast period.
  • Country-wise, India is expected to register the highest CAGR from 2024 to 2030.


Asia Pacific data book summary

Market revenue in 2023USD 1,629.6 million
Market revenue in 2030USD 3,021.9 million
Growth rate9.2% (CAGR from 2023 to 2030)
Largest segmentHereditary non-cancer testing
Fastest growing segmentHereditary Cancer Testing
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationHereditary Cancer Testing, Hereditary Non-cancer Testing
Key market players worldwideMyriad Genetics Inc, Invitae Corp, Illumina Inc, Natera Inc, Labcorp Holdings Inc, Roche Holding AG ADR, Quest Diagnostics Inc, CooperSurgical, Agilent Technologies Inc, Thermo Fisher Scientific Inc, Twist Bioscience Corp, Sophia Genetics SA, Fulgent Genetics Inc, MedGenome, Centogene NV Ordinary Shares, The Cooper Companies Inc


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 22.5% of the global hereditary testing market in 2023.
  • Globally, Europe is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 3,021.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Hereditary Testing Market Companies

Name Profile # Employees HQ Website

Asia Pacific hereditary testing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hereditary testing market will help companies and investors design strategic landscapes.


Hereditary non-cancer testing was the largest segment with a revenue share of 85.95% in 2023. Horizon Databook has segmented the Asia Pacific hereditary testing market based on hereditary cancer testing, hereditary non-cancer testing covering the revenue growth of each sub-segment from 2018 to 2030.


Major growth factors influencing Asia Pacific hereditary testing market include increasing fertility rates, rising burden of inherited genetic diseases, developing healthcare infrastructure, and growing awareness about benefits of prenatal testing & newborn screening.

The high birth rates of several developing economies in the region are responsible for an increase in several birth defects & genetic diseases in infants. As per ESCAP Online Statistical Database, 2018, the crude birth rate (births per 1,000 population) in the Asia Pacific region was 16.0 in 2018. The following figure shows the crude birth rate in different regions of Asia Pacific.

As per World Bank data, in 2016, India had a fertility rate of 2.23 births per woman, which is much higher than China’s 1.62 per woman, and 1.80 per woman in the U.S. Although India’s total fertility rate is steadily declining, its birthrate is still very high as compared to developed economies. 

Reasons to subscribe to Asia Pacific hereditary testing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific hereditary testing market databook

  • Our clientele includes a mix of hereditary testing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific hereditary testing market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific hereditary testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific hereditary testing market size, by country, 2018-2030 (US$M)

Asia Pacific Hereditary Testing Market Share, 2023 & 2030 (US$M)

Asia Pacific hereditary testing market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more